Global and Japan Streptococcus Pneumoniae Vaccine Market Insights, Forecast to 2027

Global and Japan Streptococcus Pneumoniae Vaccine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Streptococcus Pneumoniae Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Streptococcus Pneumoniae Vaccine Market Size Growth Rate by Type
1.2.2 7 -Valent
1.2.3 10 -Valent
1.2.4 13 -Valent
1.2.5 15 -Valent
1.2.6 23 -Valent
1.2.7 Other
1.3 Market by Application
1.3.1 Global Streptococcus Pneumoniae Vaccine Market Size Growth Rate by Application
1.3.2 Children under 2 Years of Age
1.3.3 Adults over 65 Years of Age
1.3.4 Addicted Smokers Between the Ages of 19 and 64
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Streptococcus Pneumoniae Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Streptococcus Pneumoniae Vaccine Revenue 2016-2027
2.1.2 Global Streptococcus Pneumoniae Vaccine Sales 2016-2027
2.2 Global Streptococcus Pneumoniae Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Streptococcus Pneumoniae Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Streptococcus Pneumoniae Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Streptococcus Pneumoniae Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Streptococcus Pneumoniae Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2022-2027)
3 Global Streptococcus Pneumoniae Vaccine Competitor Landscape by Players
3.1 Global Top Streptococcus Pneumoniae Vaccine Manufacturers by Sales
3.1.1 Global Streptococcus Pneumoniae Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Streptococcus Pneumoniae Vaccine Manufacturers by Revenue
3.2.1 Key Streptococcus Pneumoniae Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Streptococcus Pneumoniae Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Streptococcus Pneumoniae Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Streptococcus Pneumoniae Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Streptococcus Pneumoniae Vaccine Revenue in 2020
3.2.6 Global Streptococcus Pneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Streptococcus Pneumoniae Vaccine Price by Manufacturers
3.4 Global Streptococcus Pneumoniae Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Streptococcus Pneumoniae Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Streptococcus Pneumoniae Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Streptococcus Pneumoniae Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Streptococcus Pneumoniae Vaccine Market Size by Type (2016-2021)
4.1.1 Global Streptococcus Pneumoniae Vaccine Sales by Type (2016-2021)
4.1.2 Global Streptococcus Pneumoniae Vaccine Revenue by Type (2016-2021)
4.1.3 Streptococcus Pneumoniae Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Streptococcus Pneumoniae Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Streptococcus Pneumoniae Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Streptococcus Pneumoniae Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Streptococcus Pneumoniae Vaccine Market Size by Application (2016-2021)
5.1.1 Global Streptococcus Pneumoniae Vaccine Sales by Application (2016-2021)
5.1.2 Global Streptococcus Pneumoniae Vaccine Revenue by Application (2016-2021)
5.1.3 Streptococcus Pneumoniae Vaccine Price by Application (2016-2021)
5.2 Streptococcus Pneumoniae Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Streptococcus Pneumoniae Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Streptococcus Pneumoniae Vaccine Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Streptococcus Pneumoniae Vaccine Market Size YoY Growth 2016-2027
6.1.1 Japan Streptococcus Pneumoniae Vaccine Sales YoY Growth 2016-2027
6.1.2 Japan Streptococcus Pneumoniae Vaccine Revenue YoY Growth 2016-2027
6.1.3 Japan Streptococcus Pneumoniae Vaccine Market Share in Global Market 2016-2027
6.2 Japan Streptococcus Pneumoniae Vaccine Market Size by Players (International and Local Players)
6.2.1 Japan Top Streptococcus Pneumoniae Vaccine Players by Sales (2016-2021)
6.2.2 Japan Top Streptococcus Pneumoniae Vaccine Players by Revenue (2016-2021)
6.3 Japan Streptococcus Pneumoniae Vaccine Historic Market Review by Type (2016-2021)
6.3.1 Japan Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2016-2021)
6.3.2 Japan Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 Japan Streptococcus Pneumoniae Vaccine Price by Type (2016-2021)
6.4 Japan Streptococcus Pneumoniae Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Streptococcus Pneumoniae Vaccine Sales Forecast by Type (2022-2027)
6.4.2 Japan Streptococcus Pneumoniae Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 Japan Streptococcus Pneumoniae Vaccine Price Forecast by Type (2022-2027)
6.5 Japan Streptococcus Pneumoniae Vaccine Historic Market Review by Application (2016-2021)
6.5.1 Japan Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2016-2021)
6.5.2 Japan Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 Japan Streptococcus Pneumoniae Vaccine Price by Application (2016-2021)
6.6 Japan Streptococcus Pneumoniae Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Streptococcus Pneumoniae Vaccine Sales Forecast by Application (2022-2027)
6.6.2 Japan Streptococcus Pneumoniae Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 Japan Streptococcus Pneumoniae Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Streptococcus Pneumoniae Vaccine Market Size YoY Growth 2016-2027
7.2 North America Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
7.2.1 North America Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021)
7.2.2 North America Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Streptococcus Pneumoniae Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Streptococcus Pneumoniae Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Streptococcus Pneumoniae Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Streptococcus Pneumoniae Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Streptococcus Pneumoniae Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
9.2.1 Europe Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021)
9.2.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Streptococcus Pneumoniae Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
10.2.1 Latin America Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Streptococcus Pneumoniae Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Streptococcus Pneumoniae Vaccine Products Offered
12.1.5 Pfizer Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi Streptococcus Pneumoniae Vaccine Products Offered
12.2.5 Sanofi Recent Development
12.3 GSK
12.3.1 GSK Corporation Information
12.3.2 GSK Description and Business Overview
12.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GSK Streptococcus Pneumoniae Vaccine Products Offered
12.3.5 GSK Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Description and Business Overview
12.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck Streptococcus Pneumoniae Vaccine Products Offered
12.4.5 Merck Recent Development
12.5 Eli Lilly
12.5.1 Eli Lilly Corporation Information
12.5.2 Eli Lilly Description and Business Overview
12.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Eli Lilly Streptococcus Pneumoniae Vaccine Products Offered
12.5.5 Eli Lilly Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Corporation Information
12.6.2 AstraZeneca Description and Business Overview
12.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 AstraZeneca Streptococcus Pneumoniae Vaccine Products Offered
12.6.5 AstraZeneca Recent Development
12.7 Abera
12.7.1 Abera Corporation Information
12.7.2 Abera Description and Business Overview
12.7.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Abera Streptococcus Pneumoniae Vaccine Products Offered
12.7.5 Abera Recent Development
12.8 S K Chemicals
12.8.1 S K Chemicals Corporation Information
12.8.2 S K Chemicals Description and Business Overview
12.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 S K Chemicals Streptococcus Pneumoniae Vaccine Products Offered
12.8.5 S K Chemicals Recent Development
12.9 Beijing Minhai Biotechnology
12.9.1 Beijing Minhai Biotechnology Corporation Information
12.9.2 Beijing Minhai Biotechnology Description and Business Overview
12.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Products Offered
12.9.5 Beijing Minhai Biotechnology Recent Development
12.10 Baxter
12.10.1 Baxter Corporation Information
12.10.2 Baxter Description and Business Overview
12.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Baxter Streptococcus Pneumoniae Vaccine Products Offered
12.10.5 Baxter Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Streptococcus Pneumoniae Vaccine Products Offered
12.11.5 Pfizer Recent Development
12.12 Celgene Corporation
12.12.1 Celgene Corporation Corporation Information
12.12.2 Celgene Corporation Description and Business Overview
12.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Celgene Corporation Products Offered
12.12.5 Celgene Corporation Recent Development
12.13 Panacea Biotec
12.13.1 Panacea Biotec Corporation Information
12.13.2 Panacea Biotec Description and Business Overview
12.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Panacea Biotec Products Offered
12.13.5 Panacea Biotec Recent Development
12.14 Serum Institute of India
12.14.1 Serum Institute of India Corporation Information
12.14.2 Serum Institute of India Description and Business Overview
12.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Serum Institute of India Products Offered
12.14.5 Serum Institute of India Recent Development
12.15 Genentech
12.15.1 Genentech Corporation Information
12.15.2 Genentech Description and Business Overview
12.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Genentech Products Offered
12.15.5 Genentech Recent Development
12.16 Genocea Biosciences
12.16.1 Genocea Biosciences Corporation Information
12.16.2 Genocea Biosciences Description and Business Overview
12.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Genocea Biosciences Products Offered
12.16.5 Genocea Biosciences Recent Development
12.17 ImmunoBiology
12.17.1 ImmunoBiology Corporation Information
12.17.2 ImmunoBiology Description and Business Overview
12.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 ImmunoBiology Products Offered
12.17.5 ImmunoBiology Recent Development
12.18 Lupin
12.18.1 Lupin Corporation Information
12.18.2 Lupin Description and Business Overview
12.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Lupin Products Offered
12.18.5 Lupin Recent Development
12.19 Nuron Biotech
12.19.1 Nuron Biotech Corporation Information
12.19.2 Nuron Biotech Description and Business Overview
12.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Nuron Biotech Products Offered
12.19.5 Nuron Biotech Recent Development
12.20 Biogen
12.20.1 Biogen Corporation Information
12.20.2 Biogen Description and Business Overview
12.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Biogen Products Offered
12.20.5 Biogen Recent Development
12.21 Valneva Austria
12.21.1 Valneva Austria Corporation Information
12.21.2 Valneva Austria Description and Business Overview
12.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Valneva Austria Products Offered
12.21.5 Valneva Austria Recent Development
12.22 Sinovac
12.22.1 Sinovac Corporation Information
12.22.2 Sinovac Description and Business Overview
12.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Sinovac Products Offered
12.22.5 Sinovac Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Streptococcus Pneumoniae Vaccine Industry Trends
13.2 Streptococcus Pneumoniae Vaccine Market Drivers
13.3 Streptococcus Pneumoniae Vaccine Market Challenges
13.4 Streptococcus Pneumoniae Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Streptococcus Pneumoniae Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Streptococcus Pneumoniae Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 7 -Valent
Table 3. Major Manufacturers of 10 -Valent
Table 4. Major Manufacturers of 13 -Valent
Table 5. Major Manufacturers of 15 -Valent
Table 6. Major Manufacturers of 23 -Valent
Table 7. Major Manufacturers of Other
Table 8. Global Streptococcus Pneumoniae Vaccine Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 9. Global Streptococcus Pneumoniae Vaccine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Streptococcus Pneumoniae Vaccine Sales by Regions (2016-2021) & (K Units)
Table 11. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Regions (2016-2021)
Table 12. Global Streptococcus Pneumoniae Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 14. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Streptococcus Pneumoniae Vaccine Sales by Manufacturers (2016-2021) (K Units)
Table 18. Global Streptococcus Pneumoniae Vaccine Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Streptococcus Pneumoniae Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 20. Streptococcus Pneumoniae Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Streptococcus Pneumoniae Vaccine Revenue Share by Manufacturers (2016-2021)
Table 22. Global Streptococcus Pneumoniae Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Streptococcus Pneumoniae Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Streptococcus Pneumoniae Vaccine as of 2020)
Table 24. Key Manufacturers Streptococcus Pneumoniae Vaccine Price (2016-2021) (US$/Unit)
Table 25. Streptococcus Pneumoniae Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Streptococcus Pneumoniae Vaccine Product Type
Table 27. Date of International Manufacturers Enter into Streptococcus Pneumoniae Vaccine Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Streptococcus Pneumoniae Vaccine Sales by Type (2016-2021) (K Units)
Table 30. Global Streptococcus Pneumoniae Vaccine Sales Share by Type (2016-2021)
Table 31. Global Streptococcus Pneumoniae Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Streptococcus Pneumoniae Vaccine Revenue Share by Type (2016-2021)
Table 33. Streptococcus Pneumoniae Vaccine Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 34. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 35. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Streptococcus Pneumoniae Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Streptococcus Pneumoniae Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 39. Global Streptococcus Pneumoniae Vaccine Sales by Application (2016-2021) (K Units)
Table 40. Global Streptococcus Pneumoniae Vaccine Sales Share by Application (2016-2021)
Table 41. Global Streptococcus Pneumoniae Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Streptococcus Pneumoniae Vaccine Revenue Share by Application (2016-2021)
Table 43. Streptococcus Pneumoniae Vaccine Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 44. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 45. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Streptococcus Pneumoniae Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 49. Japan Streptococcus Pneumoniae Vaccine Sales (K Units) of Key Companies (2016-2021)
Table 50. Japan Streptococcus Pneumoniae Vaccine Sales Share by Company (2016-2021)
Table 51. Japan Streptococcus Pneumoniae Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 52. Japan Streptococcus Pneumoniae Vaccine Revenue Share by Company (2016-2021)
Table 53. Japan Streptococcus Pneumoniae Vaccine Sales (K Units) by Type (2016-2021)
Table 54. Japan Streptococcus Pneumoniae Vaccine Sales Share by Type (2016-2021)
Table 55. Japan Streptococcus Pneumoniae Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. Japan Streptococcus Pneumoniae Vaccine Price (US$/Unit) by Type (2016-2021)
Table 57. Japan Streptococcus Pneumoniae Vaccine Sales (K Units) by Type (2022-2027)
Table 58. Japan Streptococcus Pneumoniae Vaccine Sales Share by Type (2022-2027)
Table 59. Japan Streptococcus Pneumoniae Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. Japan Streptococcus Pneumoniae Vaccine Revenue Share by Type (2022-2027)
Table 61. Japan Streptococcus Pneumoniae Vaccine Price (US$/Unit) by Type (2022-2027)
Table 62. Japan Streptococcus Pneumoniae Vaccine Sales (K Units) by Application (2016-2021)
Table 63. Japan Streptococcus Pneumoniae Vaccine Sales Share by Application (2016-2021)
Table 64. Japan Streptococcus Pneumoniae Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. Japan Streptococcus Pneumoniae Vaccine Price (US$/Unit) by Application (2016-2021)
Table 66. Japan Streptococcus Pneumoniae Vaccine Sales (K Units) by Application (2022-2027)
Table 67. Japan Streptococcus Pneumoniae Vaccine Sales Share by Application (2022-2027)
Table 68. Japan Streptococcus Pneumoniae Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. Japan Streptococcus Pneumoniae Vaccine Revenue Share by Application (2022-2027)
Table 70. Japan Streptococcus Pneumoniae Vaccine Price (US$/Unit) by Application (2022-2027)
Table 71. North America Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021) & (K Units)
Table 72. North America Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2016-2021)
Table 73. North America Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Streptococcus Pneumoniae Vaccine Sales by Region (2016-2021) & (K Units)
Table 76. Asia Pacific Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Streptococcus Pneumoniae Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2016-2021)
Table 79. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021) & (K Units)
Table 80. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2016-2021)
Table 81. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2016-2021)
Table 83. Latin America Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021) & (K Units)
Table 84. Latin America Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Streptococcus Pneumoniae Vaccine Sales by Country (2016-2021) & (K Units)
Table 88. Middle East and Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2016-2021)
Table 91. Pfizer Corporation Information
Table 92. Pfizer Description and Business Overview
Table 93. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 94. Pfizer Streptococcus Pneumoniae Vaccine Product
Table 95. Pfizer Recent Development
Table 96. Sanofi Corporation Information
Table 97. Sanofi Description and Business Overview
Table 98. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 99. Sanofi Product
Table 100. Sanofi Recent Development
Table 101. GSK Corporation Information
Table 102. GSK Description and Business Overview
Table 103. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 104. GSK Product
Table 105. GSK Recent Development
Table 106. Merck Corporation Information
Table 107. Merck Description and Business Overview
Table 108. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. Merck Product
Table 110. Merck Recent Development
Table 111. Eli Lilly Corporation Information
Table 112. Eli Lilly Description and Business Overview
Table 113. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Eli Lilly Product
Table 115. Eli Lilly Recent Development
Table 116. AstraZeneca Corporation Information
Table 117. AstraZeneca Description and Business Overview
Table 118. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. AstraZeneca Product
Table 120. AstraZeneca Recent Development
Table 121. Abera Corporation Information
Table 122. Abera Description and Business Overview
Table 123. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Abera Product
Table 125. Abera Recent Development
Table 126. S K Chemicals Corporation Information
Table 127. S K Chemicals Description and Business Overview
Table 128. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. S K Chemicals Product
Table 130. S K Chemicals Recent Development
Table 131. Beijing Minhai Biotechnology Corporation Information
Table 132. Beijing Minhai Biotechnology Description and Business Overview
Table 133. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Beijing Minhai Biotechnology Product
Table 135. Beijing Minhai Biotechnology Recent Development
Table 136. Baxter Corporation Information
Table 137. Baxter Description and Business Overview
Table 138. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Baxter Product
Table 140. Baxter Recent Development
Table 141. Biken Corporation Information
Table 142. Biken Description and Business Overview
Table 143. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Biken Product
Table 145. Biken Recent Development
Table 146. Celgene Corporation Corporation Information
Table 147. Celgene Corporation Description and Business Overview
Table 148. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 149. Celgene Corporation Product
Table 150. Celgene Corporation Recent Development
Table 151. Panacea Biotec Corporation Information
Table 152. Panacea Biotec Description and Business Overview
Table 153. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 154. Panacea Biotec Product
Table 155. Panacea Biotec Recent Development
Table 156. Serum Institute of India Corporation Information
Table 157. Serum Institute of India Description and Business Overview
Table 158. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 159. Serum Institute of India Product
Table 160. Serum Institute of India Recent Development
Table 161. Genentech Corporation Information
Table 162. Genentech Description and Business Overview
Table 163. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 164. Genentech Product
Table 165. Genentech Recent Development
Table 166. Genocea Biosciences Corporation Information
Table 167. Genocea Biosciences Description and Business Overview
Table 168. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 169. Genocea Biosciences Product
Table 170. Genocea Biosciences Recent Development
Table 171. ImmunoBiology Corporation Information
Table 172. ImmunoBiology Description and Business Overview
Table 173. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 174. ImmunoBiology Product
Table 175. ImmunoBiology Recent Development
Table 176. Lupin Corporation

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs